Heterocyclic compounds as immunomodulators
US11608337B2 · kind B2 · utility
12Cited by
39References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 2020 |
| Grant date | Mar 21, 2023 |
| Priority date | — |
| Expiry date | Sep 25, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.